Indications
Therapeutic Asset Ratings
13,145 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
dd01
Metabolic Dysfunction-Associated Steatohepatitis
Neuraly, Inc.
P2
B
(57)
Decitabine
Acute Myeloid Leukemia By FAB Classification
University of Nebraska
P2
B
(57)
Decitabine
Primary Peritoneal Carcinoma
Roswell Park Cancer Institute
P2
B
(57)
Decitabine
Myelodysplastic/Myeloproliferative Neoplasm
University of Washington
P2
B
(57)
Defibrotide
Sickle Cell Disease
New York Medical College
P2
B
(57)
Dexasone
Angioimmunoblastic T-Cell Lymphoma
Ou Bai, MD/PHD
P2
B
(57)
Dexasone
High Grade B-Cell Lymphoma
University of California, Davis
P2
B
(57)
Dexasone
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia Consortium
P2
B
(57)
Dexasone
Hematologic Disorder
Hellenic Society of Hematology
P2
B
(57)
Dexasone
Kidney Cancer
Takeda
P2
B
(57)
Dexasone
Prostate Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(57)
Dexasone
Neutropenia
Second Affiliated Hospital, School of Medicine, Zhejiang University
P2
B
(57)
Dexasone
Plasmablastic Lymphoma
Fondazione Italiana Linfomi - ETS
P2
B
(57)
Dexasone
Adult T-Cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University
P2
B
(57)
Dexasone
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P2
B
(57)
Dextrose
Ischemic Stroke
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
P2
B
(57)
Dinaciclib
Melanoma
National Cancer Institute (NCI)
P2
B
(57)
Disitamab Vedotin
Endometrial Cancer
Seagen, a wholly owned subsidiary of Pfizer
P2
B
(57)
Docetaxel
BRCA2-Related Cancer Predisposition
Qian Qin
P2
B
(57)
Docetaxel
Chemotherapy-Induced Neuropathy
Mansoura University
P2
B
(57)
Docetaxel
Gastric Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Docetaxel
Urinary Bladder Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Docetaxel
Uterine Cervix Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Donafenib
Chemotherapy-Induced Toxicity
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P2
B
(57)
Donafenib
Digestive System Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P2
B
(57)
Showing 3026 to 3050 of 13,145 assets
Previous
Page 122 of 526
Next